SARS-CoV-2_Lambda_variant

SARS-CoV-2 Lambda variant

SARS-CoV-2 Lambda variant

Variant of SARS-CoV-2


The Lambda variant, also known as lineage C.37, is a variant of SARS-CoV-2, the virus that causes COVID-19.[1] It was first detected in Peru in August 2020.[2] On 14 June 2021, the World Health Organization (WHO) named it Lambda variant[1] and designated it as a variant of interest.[3] It has spread to at least 30 countries[4] around the world and is known to be more resistant to neutralizing antibodies compared to other strains.[5][6][7] There is evidence that suggests the Lambda variant is both more infectious and resistant to vaccines than the Alpha and/or Gamma variant.[8][9]

Mutations

The Lambda genome has the following amino acid mutations, all of which are in the virus's spike protein code: G75V, T76I, Δ246-252, L452Q, F490S, D614G and T859N.[10]

History

First samples of the Lambda variant were detected in Peru in August 2020[2] and by April 2021, over eighty percent of new cases of COVID-19 in Peru were from the new variant.[1][12] In mid-June 2021, 90.6% of new COVID-19 cases in Arequipa and 78.1% of new cases in Cusco were the Lambda variant, according to the Peruvian Ministry of Health.[13] By this time the Lambda variant had also spread throughout South America and was detected in twenty-nine countries in total, especially in Argentina, Chile and Ecuador.[12][14] The WHO designated the Lambda variant as a "variant of interest" on 14 June 2021.[1]

On 6 July 2021, Australia reported its first case of the Lambda variant in an overseas traveler who had been in a New South Wales quarantine hotel in April.[15]

On 19 July 2021, Texas reported its first case of the Lambda variant.[16] On 22 July 2021, Florida reported 126 cumulative confirmed cases of the Lambda variant.[17] On 28 July 2021, University of Miami researchers announced random sampling showed 3 percent of COVID-19 patients in Jackson Memorial Health System and at University of Miami's UHealth Tower were infected with it.[18] On 5 August 2021, Louisiana reported its first case of the Lambda variant.[19]

On 7 August 2021, Japan confirmed its first case of the Lambda variant, with the infected person arriving in Japan from Peru on 20 July.[20]

On 15 August 2021, the Philippines confirmed its first case of the Lambda variant.[21]

Statistics

More information Country, Confirmed cases ...

See also


References

  1. "Tracking SARS-CoV-2 variants". World Health Organization. Retrieved 2021-06-17.
  2. "Weekly epidemiological update on COVID-19 - 15 June 2021" (PDF) (44 ed.). World Health Organization. 15 June 2021. Retrieved 2021-08-16. Lambda has been associated with substantive rates of community transmission in multiple countries, with rising prevalence over time concurrent with increased COVID-19 incidence. The earliest sequenced samples were reported from Peru in August 2020.
  3. "Tracking SARS-CoV-2 variants". who.int. World Health Organization. Updated frequently.
  4. Kimura, Izumi; Kosugi, Yusuke; Wu, Jiaqi; Yamasoba, Daichi; Butlertanaka, Erika P.; Tanaka, Yuri L.; Liu, Yafei; Shirakawa, Kotaro; Kazuma, Yasuhiro; Nomura, Ryosuke; Horisawa, Yoshihito; Tokunaga, Kenzo; Takaori-Kondo, Akifumi; Arase, Hisashi; Saito, Akatsuki; Nakagawa, So; Sato, Kei (28 July 2021). "SARS-CoV-2 Lambda variant exhibits higher infectivity and immune resistance". bioRxiv 10.1101/2021.07.28.454085.
  5. Mohammadi, Mehrdad; Shayestehpour, Mohammad; Mirzaei, Hamed (2021-07-01). "The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines". The Brazilian Journal of Infectious Diseases. 25 (4): 101606. doi:10.1016/j.bjid.2021.101606. ISSN 1413-8670. PMC 8367756. PMID 34428473.
  6. Acevedo, Mónica L.; Alonso-Palomares, Luis; Bustamante, Andrés; Gaggero, Aldo; Paredes, Fabio; Cortés, Claudia P.; Valiente-Echeverría, Fernando; Soto-Rifo, Ricardo (2021-07-01). "Infectivity and immune escape of the new SARS-CoV-2 variant of interest Lambda". medRxiv 10.1101/2021.06.28.21259673v1.
  7. Robertson, Sally (27 June 2021). "Lambda lineage of SARS-CoV-2 has potential to become variant of concern". news-medical.net. Retrieved 2021-07-05. The Lambda variant also contained a novel deletion (Δ246-252) and multiple nonsynonymous mutations (G75V, T76I, L452Q, F490S, D614G, and T859N) in the gene that encodes the viral spike protein.
  8. "Spike Variants: Lambda variant, aka B.1.1.1". covdb.stanford.edu. Stanford University Coronavirus Antiviral & Resistance Database. 1 July 2021. Retrieved 2021-07-05.
  9. Acosta, Sebastián (2021-06-16). "Coronavirus en Perú | Minsa: El 90,6 % de los contagios en Arequipa se deben a la variante Lambda" [Coronavirus in Peru | Minsa: 90.6% of infections in Arequipa are due to the Lambda variant]. RPP (in Spanish). Retrieved 17 June 2021.
  10. EDT, Khaleda Rahman On 7/20/21 at 7:09 AM (2021-07-20). "Lambda COVID variant detected in Texas hospital". Newsweek. Retrieved 2021-07-22.{{cite web}}: CS1 maint: numeric names: authors list (link)
  11. "Japan confirms first case of lambda variant infection". The Japan Times. 2021-08-07. Archived from the original on 2021-09-29. Retrieved 2021-08-07.
  12. Garcia, Ma. Angelica (August 15, 2021). "First lambda variant case detected in the Philippines". GMA News. Retrieved August 15, 2021.
  13. "GISAID - hCov19 Variants". www.gisaid.org. Retrieved 2021-08-23.
  14. Press Release (August 15, 2021). "DOH, UP-PGC, and UP-NIH confirm additional COVID-19 variant cases including first case of Lambda variant". Department of Health, Government of the Philippines. Archived from the original on December 4, 2021. Retrieved August 23, 2021.

Share this article:

This article uses material from the Wikipedia article SARS-CoV-2_Lambda_variant, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.